Name: | COREPHARMA, L.L.C. |
Jurisdiction: | Rhode Island |
Entity type: | Foreign Limited Liability Company |
Status: | Revoked Entity |
Date of Organization in Rhode Island: | 14 Oct 2014 (11 years ago) |
Date of Dissolution: | 22 Jul 2019 (6 years ago) |
Date of Status Change: | 22 Jul 2019 (6 years ago) |
Identification Number: | 000995253 |
Place of Formation: | NEW JERSEY |
Principal Address: | 215 WOOD AVE., MIDDLESEX, NJ, 08846, USA |
Mailing Address: | 602 OFFICE CENTER DRIVE STE 200, FORT WASHINGTON, PA, 19034, USA |
Purpose: | MANUFACTURING/DISTRIBUTION OF PHARMACEUTICALS |
NAICS
325412 Pharmaceutical Preparation ManufacturingThis U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions. Learn more at the U.S. Census Bureau
Name | Role | Address |
---|---|---|
BRYAN REASONS | Manager | 215 WOOD AVE. MIDDLESEX, NJ 08846 USA |
PAUL M. BISARO | Manager | 215 WOOD AVE MIDDLESEX, NJ 08846 USA |
MARK SCHLOSSBERG | Manager | 31047 GENSTAR ROAD HAYWARD, CA 94544 USA |
Number | Name | File Date |
---|---|---|
202040597920 | Agent Resigned | 2020-05-18 |
201906400220 | Revocation Certificate For Failure to File the Annual Report for the Year | 2019-07-22 |
201992806380 | Revocation Notice For Failure to File An Annual Report | 2019-05-13 |
201752162570 | Annual Report | 2017-10-24 |
201610041500 | Annual Report | 2016-10-07 |
201588549620 | Annual Report | 2015-11-30 |
201448126770 | Application for Registration | 2014-10-14 |
Date of last update: 19 Oct 2024
Sources: Rhode Island Department of State